• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 99 of 100
Negatively-stained Hong Kong Flu Virus
Features
One shot to cure them all: The quest for the universal flu shot
By Erika FryJanuary 21, 2015
Detroit auto show and Obama on cybersecurity — 5 things to know today
Features
Detroit auto show and Obama on cybersecurity — 5 things to know today
By Laura LorenzettiJanuary 12, 2015
Shire Plc's U.K. Offices As Drugmaker Rejects Abbvie Inc.'s $46.5 Billion Offer
Shire switches from target to predator with $5.2 billion NPS buy
By Geoffrey SmithJanuary 12, 2015
A powerful new super antibiotic may be right under our feet
Tech
A powerful new super antibiotic may be right under our feet
By Laura LorenzettiJanuary 8, 2015
Flu Outbreak Continues In Bay Area
Retail
It’s a bad flu season, but that’s good news for Walgreen
By Laura LorenzettiJanuary 6, 2015
Picture taken on January 15, 2012 in Lil
Features
The U.S. has a drug shortage — and people are dying
By Mark KobaJanuary 6, 2015
J&J starts clinical trials of Ebola drug
J&J starts clinical trials of Ebola drug
By ReutersJanuary 6, 2015
Key Speakers At The Stanford Institute For Economic Policy Research Forum
Leadership
Step aside Wall Street, small pharma CEO pay reaches for the sky
By Paul HodgsonJanuary 5, 2015
Health workers in protective equipment handle a sample taken from the body of someone who is suspected to have died from Ebola virus, near Rokupa Hospital
Features
Roche wins FDA emergency approval for Ebola test
By Laura LorenzettiDecember 29, 2014
Roche Holding AG's Headquarters As Drugmaker Acquires InterMune Inc. For $8.3 Billion
Roche shares tumble after Alzheimer’s drug failure
By ReutersDecember 19, 2014
Inside Rite Aid Ahead of Earnings Reports
Features
Rite Aid’s healthcare investments are paying off
By Laura LorenzettiDecember 18, 2014
Drug-resistant infections could cost the global economy $100 trillion by 2050
Features
Drug-resistant infections could cost the global economy $100 trillion by 2050
By Laura LorenzettiDecember 12, 2014
Greg Wasson of Walgreen's in Chicago for Fotune 6-27-13
Retail
Walgreen CEO to leave after Alliance Boots deal in reversal of plan
By Phil WahbaDecember 10, 2014
Valeant Offers to Buy Allergan With Pershing's Support
Finance
Valeant puts dealmaking on hold to focus on the bottom line
By Laura LorenzettiDecember 9, 2014
Merck takes aim at superbugs with $9.5 billion deal for Cubist
Finance
Merck takes aim at superbugs with $9.5 billion deal for Cubist
By ReutersDecember 8, 2014
1...
  • 96
  • 97
  • 98
  • 99
  • 100
100
Most Popular
Success
IBM’s CEO disagrees with JPMorgan CEO Jamie Dimon’s disdain for texting in meetings: ‘Telling people they can't use their technology would be weird’placeholder alt text
By Preston ForeAugust 29, 2026
Success
Richard Branson double-booked his own job interview. The candidate stuck in traffic with him for 2.5 hours is now Virgin's CEOplaceholder alt text
By Preston ForeAugust 29, 2026
Big Tech
Tech billionaires and executives like Evan Spiegel and Peter Thiel are publicly shielding their children from the products that made them richplaceholder alt text
By Marco Quiroz-GutierrezAugust 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.